ITMI20131159A1 - USEFUL COSMETIC COMPOSITION FOR ANTI-AGE SKIN TREATMENT - Google Patents
USEFUL COSMETIC COMPOSITION FOR ANTI-AGE SKIN TREATMENT Download PDFInfo
- Publication number
- ITMI20131159A1 ITMI20131159A1 IT001159A ITMI20131159A ITMI20131159A1 IT MI20131159 A1 ITMI20131159 A1 IT MI20131159A1 IT 001159 A IT001159 A IT 001159A IT MI20131159 A ITMI20131159 A IT MI20131159A IT MI20131159 A1 ITMI20131159 A1 IT MI20131159A1
- Authority
- IT
- Italy
- Prior art keywords
- use according
- stevioside
- composition
- vegetable
- cosmetic composition
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims description 26
- 239000002537 cosmetic Substances 0.000 title claims description 9
- 238000011282 treatment Methods 0.000 title claims description 9
- UEDUENGHJMELGK-HYDKPPNVSA-N Stevioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O UEDUENGHJMELGK-HYDKPPNVSA-N 0.000 claims description 21
- OHHNJQXIOPOJSC-UHFFFAOYSA-N stevioside Natural products CC1(CCCC2(C)C3(C)CCC4(CC3(CCC12C)CC4=C)OC5OC(CO)C(O)C(O)C5OC6OC(CO)C(O)C(O)C6O)C(=O)OC7OC(CO)C(O)C(O)C7O OHHNJQXIOPOJSC-UHFFFAOYSA-N 0.000 claims description 20
- 229940013618 stevioside Drugs 0.000 claims description 20
- 235000019202 steviosides Nutrition 0.000 claims description 20
- 244000228451 Stevia rebaudiana Species 0.000 claims description 12
- 230000003712 anti-aging effect Effects 0.000 claims description 10
- 235000006092 Stevia rebaudiana Nutrition 0.000 claims description 9
- 239000006071 cream Substances 0.000 claims description 8
- 239000000284 extract Substances 0.000 claims description 8
- -1 serum Substances 0.000 claims description 6
- 239000012530 fluid Substances 0.000 claims description 5
- 235000013311 vegetables Nutrition 0.000 claims description 5
- 239000000839 emulsion Substances 0.000 claims description 4
- 241000195493 Cryptophyta Species 0.000 claims description 3
- 108010009736 Protein Hydrolysates Proteins 0.000 claims description 3
- 239000003921 oil Substances 0.000 claims description 3
- 235000019198 oils Nutrition 0.000 claims description 3
- 108090000765 processed proteins & peptides Proteins 0.000 claims description 3
- 102000004196 processed proteins & peptides Human genes 0.000 claims description 3
- 239000003531 protein hydrolysate Substances 0.000 claims description 3
- 210000002966 serum Anatomy 0.000 claims description 3
- 244000144725 Amygdalus communis Species 0.000 claims description 2
- 235000011437 Amygdalus communis Nutrition 0.000 claims description 2
- 235000007319 Avena orientalis Nutrition 0.000 claims description 2
- 241000209763 Avena sativa Species 0.000 claims description 2
- 235000007558 Avena sp Nutrition 0.000 claims description 2
- 244000021150 Orbignya martiana Species 0.000 claims description 2
- 235000014643 Orbignya martiana Nutrition 0.000 claims description 2
- 235000018936 Vitellaria paradoxa Nutrition 0.000 claims description 2
- 241001135917 Vitellaria paradoxa Species 0.000 claims description 2
- 235000020224 almond Nutrition 0.000 claims description 2
- 230000003078 antioxidant effect Effects 0.000 claims description 2
- 235000013339 cereals Nutrition 0.000 claims description 2
- 239000000499 gel Substances 0.000 claims description 2
- 239000006210 lotion Substances 0.000 claims description 2
- 239000002674 ointment Substances 0.000 claims description 2
- HOZMBDKPRFLCKN-UHFFFAOYSA-M potassium;2-[[9-(carboxymethylamino)-9-oxononanoyl]amino]acetate Chemical compound [K+].OC(=O)CNC(=O)CCCCCCCC(=O)NCC([O-])=O HOZMBDKPRFLCKN-UHFFFAOYSA-M 0.000 claims description 2
- 239000007921 spray Substances 0.000 claims description 2
- 235000015112 vegetable and seed oil Nutrition 0.000 claims description 2
- 239000008158 vegetable oil Substances 0.000 claims description 2
- 239000011782 vitamin Substances 0.000 claims description 2
- 229940088594 vitamin Drugs 0.000 claims description 2
- 229930003231 vitamin Natural products 0.000 claims description 2
- 235000013343 vitamin Nutrition 0.000 claims description 2
- 244000125300 Argania sideroxylon Species 0.000 claims 1
- 239000009429 Ginkgo biloba extract Substances 0.000 claims 1
- 229940008396 carrot extract Drugs 0.000 claims 1
- 150000001990 dicarboxylic acid derivatives Chemical class 0.000 claims 1
- 229940068052 ginkgo biloba extract Drugs 0.000 claims 1
- 235000020686 ginkgo biloba extract Nutrition 0.000 claims 1
- 229940038487 grape extract Drugs 0.000 claims 1
- 238000009472 formulation Methods 0.000 description 7
- 102000012440 Acetylcholinesterase Human genes 0.000 description 5
- 108010022752 Acetylcholinesterase Proteins 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- OSCJHTSDLYVCQC-UHFFFAOYSA-N 2-ethylhexyl 4-[[4-[4-(tert-butylcarbamoyl)anilino]-6-[4-(2-ethylhexoxycarbonyl)anilino]-1,3,5-triazin-2-yl]amino]benzoate Chemical compound C1=CC(C(=O)OCC(CC)CCCC)=CC=C1NC1=NC(NC=2C=CC(=CC=2)C(=O)NC(C)(C)C)=NC(NC=2C=CC(=CC=2)C(=O)OCC(CC)CCCC)=N1 OSCJHTSDLYVCQC-UHFFFAOYSA-N 0.000 description 4
- WRMNZCZEMHIOCP-UHFFFAOYSA-N 2-phenylethanol Chemical compound OCCC1=CC=CC=C1 WRMNZCZEMHIOCP-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 4
- OIPILFWXSMYKGL-UHFFFAOYSA-N acetylcholine Chemical compound CC(=O)OCC[N+](C)(C)C OIPILFWXSMYKGL-UHFFFAOYSA-N 0.000 description 4
- 229960004373 acetylcholine Drugs 0.000 description 4
- 239000004615 ingredient Substances 0.000 description 4
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 4
- 239000001512 FEMA 4601 Substances 0.000 description 3
- HELXLJCILKEWJH-SEAGSNCFSA-N Rebaudioside A Natural products O=C(O[C@H]1[C@@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1)[C@@]1(C)[C@@H]2[C@](C)([C@H]3[C@@]4(CC(=C)[C@@](O[C@H]5[C@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@@H](O[C@H]6[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O6)[C@H](O)[C@@H](CO)O5)(C4)CC3)CC2)CCC1 HELXLJCILKEWJH-SEAGSNCFSA-N 0.000 description 3
- QFVOYBUQQBFCRH-UHFFFAOYSA-N Steviol Natural products C1CC2(C3)CC(=C)C3(O)CCC2C2(C)C1C(C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-UHFFFAOYSA-N 0.000 description 3
- 229940022698 acetylcholinesterase Drugs 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 150000001875 compounds Chemical class 0.000 description 3
- 229940008099 dimethicone Drugs 0.000 description 3
- 239000004205 dimethyl polysiloxane Substances 0.000 description 3
- 235000013870 dimethyl polysiloxane Nutrition 0.000 description 3
- HELXLJCILKEWJH-UHFFFAOYSA-N entered according to Sigma 01432 Natural products C1CC2C3(C)CCCC(C)(C(=O)OC4C(C(O)C(O)C(CO)O4)O)C3CCC2(C2)CC(=C)C21OC(C1OC2C(C(O)C(O)C(CO)O2)O)OC(CO)C(O)C1OC1OC(CO)C(O)C(O)C1O HELXLJCILKEWJH-UHFFFAOYSA-N 0.000 description 3
- 210000000663 muscle cell Anatomy 0.000 description 3
- 229920000435 poly(dimethylsiloxane) Polymers 0.000 description 3
- 235000019203 rebaudioside A Nutrition 0.000 description 3
- QSRAJVGDWKFOGU-WBXIDTKBSA-N rebaudioside c Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]1(CC[C@H]2[C@@]3(C)[C@@H]([C@](CCC3)(C)C(=O)O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O3)O)CC3)C(=C)C[C@]23C1 QSRAJVGDWKFOGU-WBXIDTKBSA-N 0.000 description 3
- QFVOYBUQQBFCRH-VQSWZGCSSA-N steviol Chemical compound C([C@@]1(O)C(=C)C[C@@]2(C1)CC1)C[C@H]2[C@@]2(C)[C@H]1[C@](C)(C(O)=O)CCC2 QFVOYBUQQBFCRH-VQSWZGCSSA-N 0.000 description 3
- 229940032084 steviol Drugs 0.000 description 3
- 108010016626 Dipeptides Proteins 0.000 description 2
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
- QAQJMLQRFWZOBN-LAUBAEHRSA-N L-ascorbyl-6-palmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](O)[C@H]1OC(=O)C(O)=C1O QAQJMLQRFWZOBN-LAUBAEHRSA-N 0.000 description 2
- 239000011786 L-ascorbyl-6-palmitate Substances 0.000 description 2
- 230000032683 aging Effects 0.000 description 2
- 235000010385 ascorbyl palmitate Nutrition 0.000 description 2
- 229920006037 cross link polymer Polymers 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- 239000008103 glucose Substances 0.000 description 2
- 229930182478 glucoside Natural products 0.000 description 2
- 150000008131 glucosides Chemical class 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 229930182470 glycoside Natural products 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 210000002569 neuron Anatomy 0.000 description 2
- 229930188195 rebaudioside Natural products 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 210000000225 synapse Anatomy 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 2
- 230000037303 wrinkles Effects 0.000 description 2
- AJLNZWYOJAWBCR-OOPVGHQCSA-N (4s)-4-acetamido-5-[[(2s)-1-[[(2s)-1-[[(2s)-5-amino-1-[[(2s)-1-[[(2s)-1-amino-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-5-(diaminomethylideneamino)-1-oxopentan-2-yl]amino]-1,5-dioxopentan-2-yl]amino]-4-methylsulfanyl-1-oxobutan-2-yl]amino]-4-car Chemical compound OC(=O)CC[C@H](NC(C)=O)C(=C)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CCCN=C(N)N)C(N)=O AJLNZWYOJAWBCR-OOPVGHQCSA-N 0.000 description 1
- NKJOXAZJBOMXID-UHFFFAOYSA-N 1,1'-Oxybisoctane Chemical compound CCCCCCCCOCCCCCCCC NKJOXAZJBOMXID-UHFFFAOYSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- TYYHDKOVFSVWON-UHFFFAOYSA-N 2-butyl-2-methoxy-1,3-diphenylpropane-1,3-dione Chemical compound C=1C=CC=CC=1C(=O)C(OC)(CCCC)C(=O)C1=CC=CC=C1 TYYHDKOVFSVWON-UHFFFAOYSA-N 0.000 description 1
- VMVIHERWZXKSAI-UHFFFAOYSA-N 3-chloro-5-methyl-1,2-thiazol-4-one;3-methyl-1,2-thiazol-4-one Chemical compound CC1=NSCC1=O.CC1SN=C(Cl)C1=O VMVIHERWZXKSAI-UHFFFAOYSA-N 0.000 description 1
- NIXOWILDQLNWCW-UHFFFAOYSA-N Acrylic acid Chemical compound OC(=O)C=C NIXOWILDQLNWCW-UHFFFAOYSA-N 0.000 description 1
- TWCMVXMQHSVIOJ-UHFFFAOYSA-N Aglycone of yadanzioside D Natural products COC(=O)C12OCC34C(CC5C(=CC(O)C(O)C5(C)C3C(O)C1O)C)OC(=O)C(OC(=O)C)C24 TWCMVXMQHSVIOJ-UHFFFAOYSA-N 0.000 description 1
- PLMKQQMDOMTZGG-UHFFFAOYSA-N Astrantiagenin E-methylester Natural products CC12CCC(O)C(C)(CO)C1CCC1(C)C2CC=C2C3CC(C)(C)CCC3(C(=O)OC)CCC21C PLMKQQMDOMTZGG-UHFFFAOYSA-N 0.000 description 1
- ZAKOWWREFLAJOT-CEFNRUSXSA-N D-alpha-tocopherylacetate Chemical compound CC(=O)OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-CEFNRUSXSA-N 0.000 description 1
- SNPLKNRPJHDVJA-ZETCQYMHSA-N D-panthenol Chemical compound OCC(C)(C)[C@@H](O)C(=O)NCCCO SNPLKNRPJHDVJA-ZETCQYMHSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- XMSXQFUHVRWGNA-UHFFFAOYSA-N Decamethylcyclopentasiloxane Chemical compound C[Si]1(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O[Si](C)(C)O1 XMSXQFUHVRWGNA-UHFFFAOYSA-N 0.000 description 1
- 239000003109 Disodium ethylene diamine tetraacetate Substances 0.000 description 1
- 206010013786 Dry skin Diseases 0.000 description 1
- CANAPGLEBDTCAF-QHSHOEHESA-N Dulcoside A Natural products C[C@@H]1O[C@H](O[C@@H]2[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]2O[C@]34CC[C@H]5[C@]6(C)CCC[C@](C)([C@H]6CC[C@@]5(CC3=C)C4)C(=O)O[C@@H]7O[C@H](CO)[C@@H](O)[C@H](O)[C@H]7O)[C@H](O)[C@H](O)[C@H]1O CANAPGLEBDTCAF-QHSHOEHESA-N 0.000 description 1
- CANAPGLEBDTCAF-NTIPNFSCSA-N Dulcoside A Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](O[C@]23C(C[C@]4(C2)[C@H]([C@@]2(C)[C@@H]([C@](CCC2)(C)C(=O)O[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)CC4)CC3)=C)O[C@H](CO)[C@@H](O)[C@@H]1O CANAPGLEBDTCAF-NTIPNFSCSA-N 0.000 description 1
- ZGTMUACCHSMWAC-UHFFFAOYSA-L EDTA disodium salt (anhydrous) Chemical compound [Na+].[Na+].OC(=O)CN(CC([O-])=O)CCN(CC(O)=O)CC([O-])=O ZGTMUACCHSMWAC-UHFFFAOYSA-L 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000001776 FEMA 4720 Substances 0.000 description 1
- 244000194101 Ginkgo biloba Species 0.000 description 1
- 235000008100 Ginkgo biloba Nutrition 0.000 description 1
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 1
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 1
- 206010021118 Hypotonia Diseases 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- SAVLIIGUQOSOEP-UHFFFAOYSA-N N-octanoylglycine Chemical compound CCCCCCCC(=O)NCC(O)=O SAVLIIGUQOSOEP-UHFFFAOYSA-N 0.000 description 1
- YBGZDTIWKVFICR-JLHYYAGUSA-N Octyl 4-methoxycinnamic acid Chemical compound CCCCC(CC)COC(=O)\C=C\C1=CC=C(OC)C=C1 YBGZDTIWKVFICR-JLHYYAGUSA-N 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- 229920002125 Sokalan® Polymers 0.000 description 1
- 235000021355 Stearic acid Nutrition 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 235000009754 Vitis X bourquina Nutrition 0.000 description 1
- 235000012333 Vitis X labruscana Nutrition 0.000 description 1
- 240000006365 Vitis vinifera Species 0.000 description 1
- 235000014787 Vitis vinifera Nutrition 0.000 description 1
- 229940095094 acetyl hexapeptide-8 Drugs 0.000 description 1
- 108010006338 acetyl-glutamyl-glutamyl-methionyl-glutaminyl-arginyl-argininamide Proteins 0.000 description 1
- 150000001252 acrylic acid derivatives Chemical class 0.000 description 1
- 125000005250 alkyl acrylate group Chemical group 0.000 description 1
- 230000001142 anti-diarrhea Effects 0.000 description 1
- 230000002686 anti-diuretic effect Effects 0.000 description 1
- 230000002058 anti-hyperglycaemic effect Effects 0.000 description 1
- 230000003276 anti-hypertensive effect Effects 0.000 description 1
- 230000003110 anti-inflammatory effect Effects 0.000 description 1
- 230000000259 anti-tumor effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 239000010478 argan oil Substances 0.000 description 1
- 229960005193 avobenzone Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 210000004369 blood Anatomy 0.000 description 1
- 239000008280 blood Substances 0.000 description 1
- 230000036772 blood pressure Effects 0.000 description 1
- 229940051368 capryloyl glycine Drugs 0.000 description 1
- 229960001631 carbomer Drugs 0.000 description 1
- OEYIOHPDSNJKLS-UHFFFAOYSA-N choline Chemical compound C[N+](C)(C)CCO OEYIOHPDSNJKLS-UHFFFAOYSA-N 0.000 description 1
- 229960001231 choline Drugs 0.000 description 1
- 235000015165 citric acid Nutrition 0.000 description 1
- 235000009508 confectionery Nutrition 0.000 description 1
- 230000008602 contraction Effects 0.000 description 1
- ZAKOWWREFLAJOT-UHFFFAOYSA-N d-alpha-Tocopheryl acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C ZAKOWWREFLAJOT-UHFFFAOYSA-N 0.000 description 1
- GVJHHUAWPYXKBD-UHFFFAOYSA-N d-alpha-tocopherol Natural products OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 1
- 150000001991 dicarboxylic acids Chemical class 0.000 description 1
- PKPOVTYZGGYDIJ-UHFFFAOYSA-N dioctyl carbonate Chemical compound CCCCCCCCOC(=O)OCCCCCCCC PKPOVTYZGGYDIJ-UHFFFAOYSA-N 0.000 description 1
- 235000019301 disodium ethylene diamine tetraacetate Nutrition 0.000 description 1
- 239000002934 diuretic Substances 0.000 description 1
- 229940030606 diuretics Drugs 0.000 description 1
- XJFGDLJQUJQUEI-UHFFFAOYSA-N dodecyl decanoate dodecyl octanoate Chemical compound CCCCCCCCCCCCOC(=O)CCCCCCC.CCCCCCCCCCCCOC(=O)CCCCCCCCC XJFGDLJQUJQUEI-UHFFFAOYSA-N 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- FOYKKGHVWRFIBD-UHFFFAOYSA-N gamma-tocopherol acetate Natural products CC(=O)OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1 FOYKKGHVWRFIBD-UHFFFAOYSA-N 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- PFOARMALXZGCHY-UHFFFAOYSA-N homoegonol Natural products C1=C(OC)C(OC)=CC=C1C1=CC2=CC(CCCO)=CC(OC)=C2O1 PFOARMALXZGCHY-UHFFFAOYSA-N 0.000 description 1
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 1
- ZCTXEAQXZGPWFG-UHFFFAOYSA-N imidurea Chemical compound O=C1NC(=O)N(CO)C1NC(=O)NCNC(=O)NC1C(=O)NC(=O)N1CO ZCTXEAQXZGPWFG-UHFFFAOYSA-N 0.000 description 1
- 239000002955 immunomodulating agent Substances 0.000 description 1
- 229940121354 immunomodulator Drugs 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- UQSXHKLRYXJYBZ-UHFFFAOYSA-N iron oxide Inorganic materials [Fe]=O UQSXHKLRYXJYBZ-UHFFFAOYSA-N 0.000 description 1
- 235000013980 iron oxide Nutrition 0.000 description 1
- VBMVTYDPPZVILR-UHFFFAOYSA-N iron(2+);oxygen(2-) Chemical class [O-2].[Fe+2] VBMVTYDPPZVILR-UHFFFAOYSA-N 0.000 description 1
- KFVUFODCZDRVSS-XGBBNYNSSA-N iso-steviol Chemical compound C([C@]12C[C@@](C(C2)=O)(CC[C@H]11)C)C[C@H]2[C@@]1(C)CCC[C@@]2(C)C(O)=O KFVUFODCZDRVSS-XGBBNYNSSA-N 0.000 description 1
- KFVUFODCZDRVSS-UHFFFAOYSA-N isosteviol Natural products C1C(=O)C(C)(CCC23)CC21CCC1C3(C)CCCC1(C)C(O)=O KFVUFODCZDRVSS-UHFFFAOYSA-N 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 238000005259 measurement Methods 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 230000036640 muscle relaxation Effects 0.000 description 1
- 239000013642 negative control Substances 0.000 description 1
- 210000000653 nervous system Anatomy 0.000 description 1
- 239000002858 neurotransmitter agent Substances 0.000 description 1
- QIQXTHQIDYTFRH-UHFFFAOYSA-N octadecanoic acid Chemical compound CCCCCCCCCCCCCCCCCC(O)=O QIQXTHQIDYTFRH-UHFFFAOYSA-N 0.000 description 1
- OQCDKBAXFALNLD-UHFFFAOYSA-N octadecanoic acid Natural products CCCCCCCC(C)CCCCCCCCC(O)=O OQCDKBAXFALNLD-UHFFFAOYSA-N 0.000 description 1
- AEIJTFQOBWATKX-UHFFFAOYSA-N octane-1,2-diol Chemical compound CCCCCCC(O)CO AEIJTFQOBWATKX-UHFFFAOYSA-N 0.000 description 1
- 229960001679 octinoxate Drugs 0.000 description 1
- FMJSMJQBSVNSBF-UHFFFAOYSA-N octocrylene Chemical group C=1C=CC=CC=1C(=C(C#N)C(=O)OCC(CC)CCCC)C1=CC=CC=C1 FMJSMJQBSVNSBF-UHFFFAOYSA-N 0.000 description 1
- 229960000601 octocrylene Drugs 0.000 description 1
- 229940101267 panthenol Drugs 0.000 description 1
- 235000020957 pantothenol Nutrition 0.000 description 1
- 239000011619 pantothenol Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 238000002360 preparation method Methods 0.000 description 1
- RPYRMTHVSUWHSV-CUZJHZIBSA-N rebaudioside D Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RPYRMTHVSUWHSV-CUZJHZIBSA-N 0.000 description 1
- RLLCWNUIHGPAJY-SFUUMPFESA-N rebaudioside E Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O RLLCWNUIHGPAJY-SFUUMPFESA-N 0.000 description 1
- 108020003175 receptors Proteins 0.000 description 1
- 102000005962 receptors Human genes 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 230000036559 skin health Effects 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 239000008117 stearic acid Substances 0.000 description 1
- OMHUCGDTACNQEX-OSHKXICASA-N steviolbioside Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O OMHUCGDTACNQEX-OSHKXICASA-N 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 235000020238 sunflower seed Nutrition 0.000 description 1
- 239000000454 talc Substances 0.000 description 1
- 229910052623 talc Inorganic materials 0.000 description 1
- DXMJKVWTJMJRSZ-UHFFFAOYSA-N tetracyclo[11.2.1.01,10.04,9]hexadeca-2,4(9),5,7,10,12-hexaene-5-carboxylic acid Chemical compound C12=CC=C(C3)CCC23C=CC2=C1C=CC=C2C(=O)O DXMJKVWTJMJRSZ-UHFFFAOYSA-N 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000011732 tocopherol Substances 0.000 description 1
- 235000010384 tocopherol Nutrition 0.000 description 1
- 229960001295 tocopherol Drugs 0.000 description 1
- 229930003799 tocopherol Natural products 0.000 description 1
- 238000011200 topical administration Methods 0.000 description 1
- DRSKVOAJKLUMCL-MMUIXFKXSA-N u2n4xkx7hp Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(O)=O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O DRSKVOAJKLUMCL-MMUIXFKXSA-N 0.000 description 1
- 125000000391 vinyl group Chemical group [H]C([*])=C([H])[H] 0.000 description 1
- 229920002554 vinyl polymer Polymers 0.000 description 1
- 229940084883 wheat amino acids Drugs 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- GVJHHUAWPYXKBD-IEOSBIPESA-N α-tocopherol Chemical compound OC1=C(C)C(C)=C2O[C@@](CCC[C@H](C)CCC[C@H](C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-IEOSBIPESA-N 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A61Q19/08—Anti-ageing preparations
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9706—Algae
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9771—Ginkgophyta, e.g. Ginkgoaceae [Ginkgo family]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9794—Liliopsida [monocotyledons]
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Engineering & Computer Science (AREA)
- Biotechnology (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Epidemiology (AREA)
- Birds (AREA)
- Mycology (AREA)
- Botany (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Gerontology & Geriatric Medicine (AREA)
- Dermatology (AREA)
- Cosmetics (AREA)
Description
Descrizione del brevetto per invenzione industriale avente per titolo: Description of the patent for industrial invention entitled:
“COMPOSIZIONE COSMETICA UTILE PER IL TRATTAMENTO ANTIETÀ DELLA PELLE” "COSMETIC COMPOSITION USEFUL FOR ANTI-AGING SKIN TREATMENT"
Campo dell’invenzione Field of the invention
La presente invenzione riguarda l’uso di composizioni cosmetiche comprendenti estratti purificati di Stevia rebaudiana, ad alto titolo in glucosidi quali stevioside, rebaudioside e ducoside, nel trattamento antietà della pelle. The present invention relates to the use of cosmetic compositions comprising purified extracts of Stevia rebaudiana, with a high titre in glucosides such as stevioside, rebaudioside and ducoside, in the anti-aging treatment of the skin.
Stato dell’arte State of the art
Stevioside, beta-D-glucopiranosil-(1R,4aS,7S,8aR,10aS)-7-(2-O-(beta-D-glucopiranosil) alfa-D-glucopiranosilossi) 1,4a-dimetil-12-metileneperidro 7,8a-etanofenantren-1-carbossilato, è un glicoside diterpenoide, comprendente un aglicone (steviolo) e tre molecole di glucosio, che viene estratto dalle foglie di Stevia (S. rebaudiana). Stevioside, beta-D-glucopyranosyl- (1R, 4aS, 7S, 8aR, 10aS) -7- (2-O- (beta-D-glucopyranosyl) alpha-D-glucopyranosiloxy) 1,4a-dimethyl-12-methyleneperhydro 7 , 8a-ethanophenanthren-1-carboxylate, is a diterpenoid glycoside, comprising an aglycone (steviol) and three glucose molecules, which is extracted from the leaves of stevia (S. rebaudiana).
Oltre a stevioside, diversi altri composti dolci come steviobioside, rebaudioside A, B, C, D, E e ducoside A sono stati isolati dalle foglie di Stevia rebaudiana Bertoni. Tutti questi glicosidi diterpenoidi isolati hanno la stessa struttura chimica come scheletro (steviolo) ma differiscono per i residui nelle posizioni C13 e C19 (Shibata et al., 1995). I componenti principali della foglia sono stevioside (5-10% del peso totale a secco), rebaudioside A (2-4%), rebaudioside C (1-2%) e dulcoside A (0,4-0,7%) (Wood et al., 1955). In addition to stevioside, several other sweet compounds such as steviobioside, rebaudioside A, B, C, D, E and ducoside A have been isolated from the leaves of Stevia rebaudiana Bertoni. All these isolated diterpenoid glycosides have the same chemical structure as skeleton (steviol) but differ in residues in the C13 and C19 positions (Shibata et al., 1995). The main components of the leaf are stevioside (5-10% of the total dry weight), rebaudioside A (2-4%), rebaudioside C (1-2%) and dulcoside A (0.4-0.7%) ( Wood et al., 1955).
Stevioside è diventato ben noto per la sua intensa dolcezza (250-300 volte più dolce del saccarosio) e viene usato come dolcificante non calorico in diversi Paesi. Stevioside has become well known for its intense sweetness (250-300 times sweeter than sucrose) and is used as a non-calorie sweetener in several countries.
Una serie di studi hanno suggerito che, oltre a poter essere utilizzato come dolcificante, stevioside con i composti correlati, che includono rebaudioside A (secondo componente più abbondante di S. rebaudiana foglia), steviolo e isosteviolo (derivati metabolici di stevioside) può essere utilizzato a scopi terapeutici. Questi composti, infatti, sono anti-iperglicemici, anti-ipertensivi, anti-infiammatori, anti-tumorali, anti-diarrea, diuretici e immunomodulanti. È interessante notare che i loro effetti sulla glicemia e sulla pressione sanguigna sono stati osservati solo quando questi parametri sono superiori al normale. A number of studies have suggested that, in addition to being used as a sweetener, stevioside with related compounds, which include rebaudioside A (second most abundant component of S. rebaudiana leaf), steviol and isosteviol (metabolic derivatives of stevioside) can be used. for therapeutic purposes. These compounds, in fact, are anti-hyperglycemic, anti-hypertensive, anti-inflammatory, anti-tumor, anti-diarrhea, diuretics and immunomodulators. Interestingly, their effects on blood glucose and blood pressure were only observed when these parameters are above normal.
Negli ultimi decenni, è aumentata notevolmente la domanda di prodotti efficaci nel proteggere la pelle dai segni dell'invecchiamento e nel combattere i segni stessi. In recent decades, the demand for products that are effective in protecting the skin from the signs of aging and fighting the signs has increased dramatically.
Oggi più che mai, è particolarmente sentita l’esigenza di prodotti anti-invecchiamento in grado di migliorare la salute della pelle e di combattere i segni visibili dell'invecchiamento. Today more than ever, there is a particular need for anti-aging products capable of improving skin health and fighting the visible signs of aging.
Sommario dell’invenzione Summary of the invention
La presente invenzione è relativa all’uso di una composizione cosmetica comprendente Stevia rebaudiana per il trattamento antietà della pelle. The present invention relates to the use of a cosmetic composition including Stevia rebaudiana for the anti-aging treatment of the skin.
Descrizione dell’invenzione Description of the invention
Si è sorprendentemente trovato che lo stevioside può essere utilizzato nel trattamento antietà della pelle. It has surprisingly been found that stevioside can be used in the anti-aging treatment of the skin.
Pertanto la presente invenzione è relativa a una composizione cosmetica comprendente Stevia rebaudiana ad alto titolo in glucosidi quali stevioside, rebaudioside e ducoside per l’uso nel trattamento antietà della pelle. Therefore, the present invention relates to a cosmetic composition comprising Stevia rebaudiana with a high titer in glucosides such as stevioside, rebaudioside and ducoside for use in anti-aging skin treatment.
Secondo un aspetto preferito dell’invenzione, Stevia rebaudiana presente nella composizione cosmetica dell’invenzione, contiene stevioside in quantità variabile tra 0,01 mg e 5 mg sul peso totale della composizione, preferibilmente tra 0,1 mg e 0,6 mg, ancor più preferibilmente è pari a 0,5 mg. According to a preferred aspect of the invention, Stevia rebaudiana present in the cosmetic composition of the invention contains stevioside in a variable quantity between 0.01 mg and 5 mg on the total weight of the composition, preferably between 0.1 mg and 0.6 mg, also more preferably it is equal to 0.5 mg.
Secondo un aspetto preferito, la composizione può inoltre comprendere altri estratti ad attività antiossidante (quali ad esempio estratti di uva, ginkgo biloba, carota, etc.), peptidi sintetici (quali ad esempio quelli derivati da acidi bicarbossilici tra C2 e C18 (azeloil dipeptide -10 e derivati, come potassio azeloil diglicinato) ed idrolizzati proteici di origine vegetale (quali ad esempio quelli da cereali), vitamine, oli vegetali (quali ad esempio olio di argan, babassu, karité, mandorla, avena, etc.) e/o alghe vegetali e marine. According to a preferred aspect, the composition can further comprise other extracts with antioxidant activity (such as for example grape extracts, ginkgo biloba, carrot, etc.), synthetic peptides (such as for example those derived from dicarboxylic acids between C2 and C18 (azeloyl dipeptide -10 and derivatives, such as potassium azeloyl diglycinate) and protein hydrolysates of vegetable origin (such as for example those from cereals), vitamins, vegetable oils (such as argan oil, babassu, shea, almond, oat, etc.) and / or vegetable and marine algae.
La composizione può essere preparata, secondo metodiche note, in forme adatte alla somministrazione topica, ad esempio in forma di crema, crema fluida, siero, lozione, gel, pomata, cerotti, bendaggi occlusivi, emulsioni fluide, emulsioni spray, soluzioni acquose e idroalcoliche. The composition can be prepared, according to known methods, in forms suitable for topical administration, for example in the form of cream, fluid cream, serum, lotion, gel, ointment, plasters, occlusive bandages, fluid emulsions, spray emulsions, aqueous and hydroalcoholic solutions. .
La composizione cosmetica comprendente stevioside si è dimostrata efficace nel trattamento antietà della pelle, in particolare si è dimostrata la capacità di aumentare l’attività dell’enzima acetilcolinesterasi. The cosmetic composition including stevioside has proven effective in the anti-aging treatment of the skin, in particular the ability to increase the activity of the enzyme acetylcholinesterase has been shown.
E’ stato condotto un test in vitro attraverso il quale è stata misurata spettrofotometricamente l’attività enzimatica acetilcolinesterasica mediante lo sviluppo del colore giallo prodotto dalla tiocolina quando reagisce con lo ione ditiobisnitrobenzoato. An in vitro test was conducted through which the acetylcholinesterase enzymatic activity was measured spectrophotometrically by developing the yellow color produced by thiocholine when it reacts with the dithiobisnitrobenzoate ion.
La acetilcolinesterasi si trova nelle sinapsi tra le cellule nervose e quelle muscolari. Quando una cellula nervosa motrice riceve il corretto segnale dal sistema nervoso, rilascia acetilcolina nelle sue sinapsi con le cellule muscolari. Qui l'acetilcolina si lega ai recettori sulle cellule muscolari, innescando il processo di contrazione. Naturalmente, quando il segnale finisce, il neurotrasmettitore deve essere distrutto. Lo smaltimento delle vecchie molecole di acetilcolina è il compito della acetilcolinesterasi. Un aumento dell’attività dell’enzima in presenza di acetilcolina, porta ad un aumento della quantità di colina e al rilassamento muscolare. Acetylcholinesterase is found in the synapses between nerve and muscle cells. When a motor nerve cell receives the correct signal from the nervous system, it releases acetylcholine into its synapses with muscle cells. Here acetylcholine binds to receptors on muscle cells, triggering the contraction process. Of course, when the signal ends, the neurotransmitter must be destroyed. The disposal of the old acetylcholine molecules is the task of the acetylcholinesterase. An increase in the activity of the enzyme in the presence of acetylcholine leads to an increase in the amount of choline and muscle relaxation.
La composizione secondo la presente invenzione è in grado di agire direttamente sull’enzima acetilcolinesterasi aumentando la produzione di tiocolina in modo modo-risposta. The composition according to the present invention is able to act directly on the acetylcholinesterase enzyme by increasing the production of thiocholine in a response mode.
L’effetto massimo si riscontra alla concentrazione di 0,5% p/p di stevioside nella composizione. The maximum effect is found at the concentration of 0.5% w / w of stevioside in the composition.
Si è anche evidenziato che il prodotto risulta essere molto più attivo di un prodotto di riferimento Acetil Esapeptide 8, ampiamente utilizzato in preparazioni cosmetiche per il trattamento antietà ed antirughe. It has also been shown that the product is much more active than a reference product Acetyl Hexapeptide 8, widely used in cosmetic preparations for anti-aging and anti-wrinkle treatments.
La velocità di formazione della tiocolina in presenza del campione contenente stevioside allo 0,5% è di 2,8 più alta di quella della reazione del controllo negativo. The rate of thiocholine formation in the presence of the sample containing 0.5% stevioside is 2.8 higher than that of the negative control reaction.
Per valutare poi gli effetti sulla pelle si è passati alla valutazione di tutti i parametri caratteristici ed utili per misurare l’effetto antietà su volontari che hanno applicato per 2 settimane una crema contenente estratto di Stevia rebaudiana purificato in stevioside. To then evaluate the effects on the skin, all the characteristic and useful parameters for measuring the anti-aging effect were evaluated on volunteers who applied a cream containing Stevia rebaudiana extract purified in stevioside for 2 weeks.
Attraverso misurazioni con Visioscan si è potuto valutare i seguenti parametri Volume, NRJ (Energy), Contrasto, Ser (rugosità totale), Sesm (finezza), Sew (rughe), R3 (rugosità media), R5 (rugosità aritmetica totale). Sono state valutate anche alcune proprietà meccaniche della pelle, tra cui R2 (elasticità), R4 (fatica elastica), R6 (viscoelasticità), R9. Through measurements with Visioscan it was possible to evaluate the following parameters Volume, NRJ (Energy), Contrast, Ser (total roughness), Sesm (fineness), Sew (wrinkles), R3 (average roughness), R5 (total arithmetic roughness). Some mechanical properties of the skin were also evaluated, including R2 (elasticity), R4 (elastic fatigue), R6 (viscoelasticity), R9.
I dati ottenuti dimostrano un generale aumento di tutti i parametri collegati alla rugosità cutanea già dopo soli 15 giorni, relativamente al suo assottigliamento ed elasticità, dopo 15 giorni di applicazione di una crema contenente un estratto di Stevia rebaudiana purificato allo 0,5% p/p in stevioside. The data obtained show a general increase in all parameters related to skin roughness already after only 15 days, relative to its thinning and elasticity, after 15 days of application of a cream containing a purified Stevia rebaudiana extract at 0.5% w / p in stevioside.
Gli esempi di seguito riportati illustrano ulteriormente l’invenzione. Esempi The examples below further illustrate the invention. Examples
Gli ingredienti delle formulazioni di seguito esemplificate sono indicati utilizzando la nomenclatura INCI. The ingredients of the formulations exemplified below are indicated using the INCI nomenclature.
Esempio di formulazione 1 Formulation example 1
La composizione di una formulazione secondo l’invenzione in forma di The composition of a formulation according to the invention in the form of
crema fluida è riportata nella tabella 1. fluid cream is shown in table 1.
Tabella 1 Table 1
Ingredienti (Nome INCI) Ingredients (INCI name)
da % a % Stevioside 0,1 1,0 Water q.b. a 100 Disodium edta 0,01000 5,00000 Sodium benzoate 0,10000 3,00000 Carbomer 0,10000 2,00000 Acrylates/c10-30 alkyl acrylate crosspolymer 0,05000 2,00000 Sunflower seed oil glycerides 0,00100 5,00000 Coco-caprylate/caprate 0,01000 5,00000 Dicaprylyl ether 1,00000 10,00000 Ascorbyl palmitate 0,01000 1,00000 Algae extract 0,10000 5,00000 Phenethyl alcohol 0,05000 1,50000 Caprylyl glycol 0,05000 1,50000 Capryloyl glycine 0,05000 1,50000 Potassium lauroyl wheat amino acids 0,05000 15,00000 Esempio di formulazione 2 % to% Stevioside 0.1 1.0 Water q.s. a 100 Disodium edta 0.01000 5.00000 Sodium benzoate 0.10000 3.00000 Carbomer 0.10000 2.00000 Acrylates / c10-30 alkyl acrylate crosspolymer 0.05000 2.00000 Sunflower seed oil glycerides 0.00100 5.00000 Coco -caprylate / caprate 0,01000 5,00000 Dicaprylyl ether 1,00000 10,00000 Ascorbyl palmitate 0,01000 1,00000 Algae extract 0,10000 5,00000 Phenethyl alcohol 0,05000 1,50000 Caprylyl glycol 0,05000 1,50000 Capryloyl glycine 0.05000 1.50000 Potassium lauroyl wheat amino acids 0.05000 15.00000 Formulation example 2
La composizione di una formulazione secondo l’invenzione in forma di The composition of a formulation according to the invention in the form of
crema viso antirughe è riportata nella tabella 2. wrinkle face cream is shown in table 2.
Tabella 2 Table 2
Ingredienti (Nome INCI) Ingredients (INCI name)
da % a % Polyglyceryl 3 Rice Branate 1 10 Dicaprylyl Carbonate 0,5 5 Stearic Acid 0,5 5 Ethylhexyl methoxycinnamate 0,5 10 Butyl methoxydibenzoylmethane 0,1 2 Octocrylene 0,1 5 Phenethyl alcohol 0,5 5 Tocopheryl Acetate 0,01 0,1 Tocopherol, Lecithin, Ascorbyl Palmitate, Citric Acid 0,05 0,05 Aqua q.b. q.b. Xanthan Gum 0,3 0,3 Glycerin 2 2 Mica, Titanium Dioxide, Iron Oxides q.b. q.b. Titanium Dioxide 0,5 15 Talc 0,1 5 Cocoyl proline 0,5 5 Dimethicone 0,1 2 Cyclopentasiloxane, Dimethicone/Vinyl Dimethicone % to% Polyglyceryl 3 Rice Branate 1 10 Dicaprylyl Carbonate 0,5 5 Stearic Acid 0,5 5 Ethylhexyl methoxycinnamate 0,5 10 Butyl methoxydibenzoylmethane 0,1 2 Octocrylene 0,1 5 Phenethyl alcohol 0,5 5 Tocopheryl Acetate 0,01 0.1 Tocopherol, Lecithin, Ascorbyl Palmitate, Citric Acid 0.05 0.05 Aqua q.s. q.s. Xanthan Gum 0,3 0,3 Glycerin 2 2 Mica, Titanium Dioxide, Iron Oxides q.s. q.s. Titanium Dioxide 0.5 15 Talc 0.1 5 Cocoyl proline 0.5 5 Dimethicone 0.1 2 Cyclopentasiloxane, Dimethicone / Vinyl Dimethicone
Crosspolymer<0,01 2>Stevioside 0,01 5 Azeloyl bis dipeptide 10 0,5 0,5 Fragrance 0,2 0,2 Esempio di formulazione 3 Crosspolymer <0.01 2> Stevioside 0.01 5 Azeloyl bis dipeptide 10 0.5 0.5 Fragrance 0.2 0.2 Formulation example 3
La composizione di una formulazione secondo l’invenzione in forma di The composition of a formulation according to the invention in the form of
siero lifting è riportata nella tabella 3. lifting serum is shown in table 3.
Tabella 3 Table 3
Ingredienti (Nome INCI) Ingredients (INCI name)
da % a % Water 0,01000 1,00000 Stevioside 0,50000 1,00000 Hydroxyethylcellulose 0,10000 1,00000 Panthenol 0,10000 10,00000 Glycerin 0,05000 1,00000 Imidazolidinyl urea 0,00100 0,10000 Methylchloroisothiazolinone methylisothiazolinone 0,01000 0,1 Alga Ahnfeldtia concinna 1,00000 10,00000 % to% Water 0.01000 1.00000 Stevioside 0.50000 1.00000 Hydroxyethylcellulose 0.10000 1.00000 Panthenol 0.10000 10.00000 Glycerin 0.05000 1.00000 Imidazolidinyl urea 0.00100 0.10000 Methylchloroisothiazolinone methylisothiazolinone 0 , 01000 0.1 Alga Ahnfeldtia concinna 1.00000 10.00000
Claims (10)
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001159A ITMI20131159A1 (en) | 2013-07-10 | 2013-07-10 | USEFUL COSMETIC COMPOSITION FOR ANTI-AGE SKIN TREATMENT |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT001159A ITMI20131159A1 (en) | 2013-07-10 | 2013-07-10 | USEFUL COSMETIC COMPOSITION FOR ANTI-AGE SKIN TREATMENT |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ITMI20131159A1 true ITMI20131159A1 (en) | 2015-01-11 |
Family
ID=49085120
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IT001159A ITMI20131159A1 (en) | 2013-07-10 | 2013-07-10 | USEFUL COSMETIC COMPOSITION FOR ANTI-AGE SKIN TREATMENT |
Country Status (1)
| Country | Link |
|---|---|
| IT (1) | ITMI20131159A1 (en) |
Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS548728A (en) * | 1977-06-21 | 1979-01-23 | Lion Corp | Base material for cosmetics |
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| WO2006010590A1 (en) * | 2004-07-30 | 2006-02-02 | Maycos Italiana Di Comini Miro & C. S.A.S. | N-acylated derivatives of dicarboxylic acids with amino acids and vegetable protein hydrolysates and their use in cosmetics and pharmaceuticals |
| WO2013093881A1 (en) * | 2011-12-23 | 2013-06-27 | L'oreal | Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes |
-
2013
- 2013-07-10 IT IT001159A patent/ITMI20131159A1/en unknown
Patent Citations (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS548728A (en) * | 1977-06-21 | 1979-01-23 | Lion Corp | Base material for cosmetics |
| JP2003192566A (en) * | 2001-12-27 | 2003-07-09 | Nonogawa Shoji Kk | Cosmetic |
| WO2006010590A1 (en) * | 2004-07-30 | 2006-02-02 | Maycos Italiana Di Comini Miro & C. S.A.S. | N-acylated derivatives of dicarboxylic acids with amino acids and vegetable protein hydrolysates and their use in cosmetics and pharmaceuticals |
| WO2013093881A1 (en) * | 2011-12-23 | 2013-06-27 | L'oreal | Cosmetic use of steviol, of a steviol glycoside derivative or of one of their isomers to stimulate, restore or regulate the metabolism of the cells of the skin and semimucus membranes |
Non-Patent Citations (2)
| Title |
|---|
| DATABASE GNPD [Online] MINTEL; 28 February 2013 (2013-02-28), "Aloe Face Glow Cream", XP002723493, Database accession no. 2001708 * |
| DATABASE GNPD [Online] MINTEL; 29 February 2012 (2012-02-29), XP002723494, Database accession no. 1730976 * |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023133599A (en) | Composition for improving dermopathy | |
| EP3648784B1 (en) | Compounds useful for the treatment and/or care of the skin, hair, nails and/or mucous membranes | |
| US20090042846A1 (en) | Topical Delivery System for Phytosterols | |
| US10335354B2 (en) | Topical cosmetic treatment of skin and scalp and corresponding active ingredient based on an extract of Apium graveolens | |
| TW201438757A (en) | External dermal composition for anti-ageing and method for producing the same | |
| JP2006206599A (en) | Use of beta-endorphin or agent with beta-endorphin-like activity in cosmetic and dermatology | |
| US20200222294A1 (en) | Vegfc production promoter | |
| ES2731820T3 (en) | Schizandra fruit peptide and bearish extract and improvement of the cutaneous neurosensory system response | |
| JP6235855B2 (en) | The composition for hair containing Usbenia mallow or Bukuryo, and caffeine or cacao butter. | |
| KR20160020217A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising fargesin | |
| KR20160020253A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising atractylenolide I | |
| ITMI20131159A1 (en) | USEFUL COSMETIC COMPOSITION FOR ANTI-AGE SKIN TREATMENT | |
| KR20160020214A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising magnolin | |
| KR20160019807A (en) | Cosmetic or pharmaceutical composition for skin elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising Docetaxel or a pharmaceutically acceptable salt thereof | |
| KR20160020242A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising parthenolide | |
| KR20200066443A (en) | A pharmaceutical composition for preventing or treating aging or an aging-related disease comprising an anthocyanin-polysaccharide complex as an active ingredient | |
| JP2023054706A (en) | Skin beauty cosmetic | |
| KR20160020241A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising prim-O-glucosylcimifugin or a pharmaceutically acceptable salt thereof | |
| KR20160020213A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising isopimpinellin | |
| KR20160019765A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, or skin moisturizing comprising dihydroartemisinin | |
| KR20160019769A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising cordycepin or a pharmaceutically acceptable salt thereof | |
| KR20160020218A (en) | Cosmetic or pharmaceutical composition for melanism, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising monomyristin or a pharmaceutically acceptable salt thereof | |
| KR20160019806A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, skin moisturizing or anti-inflammation comprising cytisine or a pharmaceutically acceptable salt thereof | |
| KR20160020250A (en) | Cosmetic or pharmaceutical composition for skin whitening, elasticity, anti-wrinkle, or skin moisturizing comprising Wogonoside or a pharmaceutically acceptable salt thereof | |
| KR20160019817A (en) | COSMETIC OR PHARMACEUTICAL COMPOSITION FOR SKIN WHITENING, ELASTICITY, ANTI-WRINKLE, SKIN MOISTURIZING OR ANTI-INFLAMMATION COMPRISING α-CYPERONE |